Home Tarceva 
Add to favorites Print preview Recommend this page to a colleague

About Tarceva®

Tarceva© is a HER1/EGFR tyrosine kinase inhibitor with proven safety and tolerability...

Mode of action

Check here the Tarceva® (erlotinib) mode of action in detail.


Efficacy

Tarceva©, a highly potent, selective and orally available human epidermal growth factor receptor (HER1/EGFR) tyrosine-kinase (TK) inhibitor.

Administration

To know the indication and treatment regimens with Tarceva® (erlotinib) click next.

 
 
Privacy Policy | Legal Statement
The information on this Web site is intended only for visitors from Aruba, Bahamas, Barbados, Bermuda, Curacao, Jamaica, St. Maarten, St. Lucia and Trinidad & Tobago
All rights reserved © 2008 F. Hoffmann-La Roche Ltd.